细胞因子风暴综合征的化物疗法
Jan-Inge Henter1, Tatiana von Bahr Greenwood2
1Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, and Astrid Lindgren Children's Hospital, Karolinska University Hospital Solna, Stockholm, Sweden. jan-inge.henter@ki.se.
Advances in experimental medicine and biology
|August 8, 2024
概括
乙胺和皮质类固醇显著改善了血细胞性淋巴细胞细胞瘤 (HLH) 的存活率. 这种疗法对原发性HLH至关重要,对严重的二次HLH和细胞因子风暴综合征有益.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 血细胞淋巴细胞细胞瘤 (HLH) 是一种危及生命的超炎症综合征.
- 与皮质类固醇结合的埃托是HLH的基石疗法,大大提高了生存率.
- 埃托的疗效扩展到细胞因子风暴综合征 (CSS) 和二次HLH (sHLH).
研究的目的:
- 审查埃托波西德在管理初级和二级HLH中的作用.
- 突出埃托波西德在抑制炎症和促进亡方面的作用机制.
- 强调及时诊断和治疗sHLH的重要性.
主要方法:
- 对HLH的以太基治疗方案的审查 (例如,HLH-94,HLH-2004).
- 分析埃托波西德的生物效应,包括T细胞缺失和细胞因子抑制.
- 在二次HLH,CSS和巨细胞激活综合征 (MAS) 中检查etoposide的应用.
主要成果:
- 基于 Etoposide 的方案使得初级 HLH 的5年生存率从 < 5% 增加到 ~ 60%.
- 乙胺可选择性地删除激活的T细胞并抑制炎症性细胞因子的产生.
- 埃托化物促进了亡,而不是亡,减轻了系统性炎症.
结论:
- 乙化物是HLH,CSS和MAS的重要治疗剂.
- 通过优化埃托胺协议,可以进一步改善HLH存活率.
- 提高对sHLH的认识和及时干预对于有效治疗至关重要.
相关概念视频
Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
186
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
186
Heart Failure Drugs: Inotropic Agents
548
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
548
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
240
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
240


